Diversified Trust’s Oncternal Therapeutics ONCT Stock Holding History
Bought
Maintained
Sold
Other funds holding ONCT
Diversified Trust's ONCT Position: Q4 2016 in Review
Diversified Trust sold out of Oncternal Therapeutics (ONCT) in Q4 2016, closing a stake of 14 shares — an estimated $15K sold.
Diversified Trust first reported a position in ONCT in Q3 2013 and held it in 5 quarters. The position peaked at $217K in Q3 2013. 21 funds tracked by Wall St. Rank hold ONCT as of Q4 2016.
- Diversified Trust reported no remaining Oncternal Therapeutics position as of Q4 2016 after selling out during the quarter.
- Diversified Trust sold 14 Oncternal Therapeutics shares in Q4 2016, an estimated $15K.
- Diversified Trust first reported a position in Oncternal Therapeutics in Q3 2013 and held it in 5 quarters.
- Diversified Trust's Oncternal Therapeutics position peaked at $217K in Q3 2013.
- 21 funds tracked by Wall St. Rank held Oncternal Therapeutics as of Q4 2016.
Based on Diversified Trust's 13F filing for Q4 2016, filed 22 Feb 2017.